Clinical trial · Observational
Application of Antiosteoporosis Therapy in Osteolysis
Efficacy and Safety of Antiosteoporosis Therapy in Patients After Bone Tumor Resection: a Multicenter, Real-world Prospective Cohort Observational Study
NCT05617846CI-TRIAL-00073068not yet recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To report the postoperative complications and limb function of patients with osteolysis after surgery for bone tumors of the extremities who received anti-osteoporosis therapy in Henan Cancer Hospital in the next 10 years.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Complication | — | UNRESOLVED | — |
| Limb; Fusion | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Anti-osteoporosis therapy | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Intervention group
- description
- Patients who received antiosteoporosis therapy after bone tumor resection
- interventionNames
- Other: Anti-osteoporosis therapy
- label
- Control group
- description
- Patients who underwent bone tumor resection without antiosteoporosis therapy
Primary outcomes (2)
- measure
- Complications
- timeFrame
- Collected from the beginning of treatment to 24 months after treatment.
- description
- The incidence of complications after anti-osteoporosis treatment was collected and the severity of complications was evaluated according to CTCAE5.0.
- measure
- Limb function
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: 1. No age restriction, male or female. 2. A subtype of bone tumor (including benign, malignant, and metastatic cancer) was confirmed in the pathology department of the research institution. 3. Received excision of bone tumor in research institution. Exclusion Criteria: Not applicable.
References
Publications (0)
Data not yet available
No reference posted for this study.